CMS proposed in July to expedite its payment reduction for some 340B items and services until it recoups $7.8 billion. Hospital systems are pushing back. To compensate for underpayments in the 340B ...

Hospitals and major drugmakers are battling over the financial impact of a government pilot program that could shake up how medicines are steeply discounted for low-income and uninsured patients.

A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel ...

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...

The nonpartisan scorekeeper’s new report reinforces longstanding concerns about the 340B drug discount program, including ...

A bipartisan group of 163 lawmakers is urging the Department of Health and Human Services (HHS) to cancel an upcoming pilot ...

More than 160 lawmakers have urged the Trump administration to abandon a newly announced pilot program that would allow ...

A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) pursues its 340B Rebate Model Pilot Program (the “Pilo ...

Congress is considering a new bill that, in theory, would boost low-income patients’ - especially Latinos’ - access to ...

The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize ...

OPINION- As a healthcare researcher and business owner in California, I’ve seen first-hand how rising health care costs ...